Post navigation Emergent BioSolutions authorizes $50 million stock repurchase programGinkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business